ISSN Print 2500–1094
ISSN Online 2542–1204
BIOMEDICAL JOURNAL OF PIROGOV UNIVERSITY (MOSCOW, RUSSIA)
ORIGINAL RESEARCH
Effectiveness and safety of treatment with domestic cepeginterferon alpha-2b in patients with chronic hepatitis C infection. Actual clinical experience
About authors
1 Department of Infectious Diseases, Faculty of Medical and Preventive Care,Kazan State Medical University, Kazan, Russia
2 Diagnostic and Consultation Unit,Agafonov Republican Clinical Hospital of Infectious Diseases, Kazan, Russia
3 Department of Dental Therapy, Faculty of Dentistry,Kazan State Medical University, Kazan, Russia
Correspondence should be addressed: Svetlana Tkacheva
ul. Butlerova, d. 49, Kazan, Russia, 420012; ur.liam@umgk-avehcakt
About paper
All authors' contribution to this work is equal: selection and analysis of literature, planning of the manuscript's structure, data interpretation, drafting of the manuscript, editing.
Received: 2017-02-09
Accepted: 2017-03-10
Published online: 2017-06-02
|
Distribution of patients into groups based on the type of virologic response. Each patient can be included into more than one group depending on his/her response to therapy
Blood counts of patients with chronic HCV infection before, during and 24 weeks after the antiviral therapy. Data are represented as M ± m, n = 37
Note. * — р < 0.05, ** — р < 0.01, *** — р < 0.001 when comparing blood counts before and during the treatment.
